Winton Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,617
| Closed | -$303K | – | 894 |
|
|
2023
Q3 | $303K | Sell |
2,617
-12
| -0.5% | -$1.39K | 0.02% | 547 |
|
|
2023
Q2 | $270K | Sell |
2,629
-8,275
| -76% | -$851K | 0.02% | 562 |
|
|
2023
Q1 | $1.19M | Sell |
10,904
-621
| -5% | -$67.8K | 0.07% | 381 |
|
|
2022
Q4 | $1.31M | Sell |
11,525
-2,080
| -15% | -$237K | 0.09% | 333 |
|
|
2022
Q3 | $842K | Buy |
13,605
+3,548
| +35% | +$220K | 0.06% | 470 |
|
|
2022
Q2 | $802K | Buy |
+10,057
| New | +$802K | 0.04% | 554 |
|
|
2022
Q1 | – | Sell |
-3,304
| Closed | -$356K | – | 1205 |
|
|
2021
Q4 | $356K | Buy |
3,304
+1,179
| +55% | +$127K | 0.02% | 778 |
|
|
2021
Q3 | $233K | Buy |
+2,125
| New | +$233K | 0.01% | 1188 |
|
|
2021
Q2 | – | Sell |
-3,213
| Closed | -$296K | – | 1565 |
|
|
2021
Q1 | $296K | Buy |
+3,213
| New | +$296K | 0.02% | 1151 |
|
|
2020
Q4 | – | Sell |
-24,591
| Closed | -$1.91M | – | 1622 |
|
|
2020
Q3 | $1.91M | Sell |
24,591
-21,434
| -47% | -$1.66M | 0.06% | 547 |
|
|
2020
Q2 | $2.56M | Sell |
46,025
-52,395
| -53% | -$2.91M | 0.07% | 527 |
|
|
2020
Q1 | $2.92M | Sell |
98,420
-91,434
| -48% | -$2.71M | 0.08% | 444 |
|
|
2019
Q4 | $6.87M | Buy |
189,854
+147,380
| +347% | +$5.34M | 0.1% | 363 |
|
|
2019
Q3 | $1.16M | Buy |
42,474
+19,400
| +84% | +$528K | 0.01% | 765 |
|
|
2019
Q2 | $555K | Buy |
+23,074
| New | +$555K | 0.01% | 636 |
|